Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Reinders

Showing results (211-220 of 214) with videos related to

Pageof 22
Sort By:
You have reached the last page of results.This site can display upto 214 results.
The Lancet. Infectious Diseases|November 10, 2022
Alternative strategies to increase the immunogenicity of COVID-19 vaccines in kidney transplant recipients not responding to two or three doses of an mRNA vaccine (RECOVAC): a randomised clinical trialMarcia M L Kho, A Lianne Messchendorp, Sophie C Frölke, et al.
Journal of the American Society of Nephrology : JASN|March 11, 2014
Hematopoietic microRNA-126 protects against renal ischemia/reperfusion injury by promoting vascular integrityRoel Bijkerk, Coen van Solingen, Hetty C de Boer, et al.
Transplantation|November 10, 2021
The RECOVAC Immune-response Study: The Immunogenicity, Tolerability, and Safety of COVID-19 Vaccination in Patients With Chronic Kidney Disease, on Dialysis, or Living With a Kidney TransplantJan-Stephan F Sanders, Frederike J Bemelman, A Lianne Messchendorp, et al.
Nature Genetics|October 28, 2022
Adult human kidney organoids originate from CD24<sup>+</sup> cells and represent an advanced model for adult polycystic kidney diseaseYaoxian Xu, Christoph Kuppe, Javier Perales-Patón, et al.
Pageof 22

Showing results (211-220 of 214) with videos related to

Sort By:
Pageof 22
You have reached the last page of results.This site can display upto 214 results.
The Lancet. Infectious Diseases|November 10, 2022
Alternative strategies to increase the immunogenicity of COVID-19 vaccines in kidney transplant recipients not responding to two or three doses of an mRNA vaccine (RECOVAC): a randomised clinical trialMarcia M L Kho, A Lianne Messchendorp, Sophie C Frölke, et al.
Journal of the American Society of Nephrology : JASN|March 11, 2014
Hematopoietic microRNA-126 protects against renal ischemia/reperfusion injury by promoting vascular integrityRoel Bijkerk, Coen van Solingen, Hetty C de Boer, et al.
Transplantation|November 10, 2021
The RECOVAC Immune-response Study: The Immunogenicity, Tolerability, and Safety of COVID-19 Vaccination in Patients With Chronic Kidney Disease, on Dialysis, or Living With a Kidney TransplantJan-Stephan F Sanders, Frederike J Bemelman, A Lianne Messchendorp, et al.
Nature Genetics|October 28, 2022
Adult human kidney organoids originate from CD24<sup>+</sup> cells and represent an advanced model for adult polycystic kidney diseaseYaoxian Xu, Christoph Kuppe, Javier Perales-Patón, et al.
Pageof 22